
RxSight (RXST) Stock Forecast & Price Target
RxSight (RXST) Analyst Ratings
Bulls say
RxSight is facing some short-term challenges with declines in utilization and competitive trialing, leading to a revised revenue outlook. However, their long-term prospects remain strong with a collaboration with ALC for development of adjustable IOLs and upcoming next-generation lenses. With steady growth expected in the future and a solid financial standing, RxSight presents as a promising investment opportunity.
Bears say
RxSight is currently struggling due to disappointing underlying trends and limited growth, but its collaboration with ALC highlights the value and uniqueness of its technology. While maintaining a "Buy" rating for now, we intend to revisit our outlook after RxSight releases its full 2Q26 results and expect cash burn to improve with a larger portion of revenue coming from light adjustable lenses.
This aggregate rating is based on analysts' research of RxSight and is not a guaranteed prediction by Public.com or investment advice.
RxSight (RXST) Analyst Forecast & Price Prediction
Start investing in RxSight (RXST)
Order type
Buy in
Order amount
Est. shares
0 shares